Spero

New Ventures

 

Spero New Ventures is the innovation engine of Spero Therapeutics. We aim to identify and explore exciting new technologies that will feed our therapeutic pipeline. We are interested in early-stage projects that have the potential to be developed into novel therapies for any applications that involve the immune system (cancer, infectious disease, inflammatory/auto-immune disease, etc.). These can come from diverse fields such as cell therapy, synthetic biology, vaccine development, protein degradation, and others. Building from our extensive expertise translating early research into successful new therapies, our New Ventures team will collaborate with you to generate drug development programs, evaluate your technology, and eventually transition to our clinical development team to bring your innovations to patients in need.  

If you are an academic researcher, or a company looking to collaborate with an agile, innovative, and successful drug development organization to deliver important new medicines to patients, we’d be delighted to hear from you to discuss how we might be able to work together. Contact us at SNV@sperotherapeutics.com or call and leave us a message at (857) 242-1506.

MIKE PUCCI

Executive Director

TOM PARR

Chief Science Officer

JONATHAN KOTULA

Director of New Ventures

Let's Connect